The use of recombinant DNA technology for the development of a bluetongue virus subunit vaccine

Loading...
Thumbnail Image

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Published by The Government Printer, Pretoria

Abstract

The double-stranded RNA gene coding for the surface antigen responsible for inducing neutralising antibodies has been isolated, converted to DNA, and cloned in the plasmid pBR322. So far, only plasmids containing inserts smaller than the gene have been obtained. Possible strategies for the development of a bluetongue virus subunit vaccine are discussed.

Description

The articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat XI Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.

Keywords

Veterinary medicine

Sustainable Development Goals

Citation

Huismans, H 1985, 'The use of recombinant DNA technology for the development of a bluetongue virus subunit vaccine’, Onderstepoort Journal of Veterinary Research, vol. 52, no. 3, pp. 149-151.